We use cookies for a better user experience. Read our Privacy Policy

I Agree

Acute Kidney Injury Treatment Market

Acute Kidney Injury Treatment Market (Treatment: Dialysis and Supportive Care; and End-user: Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Acute Kidney Injury Treatment Market Outlook 2031

  • The global industry was valued at US$ 1.5 Bn in 2021
  • It is projected to grow at a CAGR of 7.5% between 2022 and 2031 and reach more than US$ 3.0 Bn by the end of 2031

Analysts’ Viewpoint

The global acute kidney injury treatment market development is driven by the increase in geriatric patient population, surge in incidence of kidney damage cases, and rise in prevalence of chronic diseases such as hypertension and diabetes across the globe. Growth in number of dialysis centers, increase in critical care admissions, presence of large geriatric population, and government initiatives to improve healthcare sector are the key market movers.

Leading companies are focusing on the development of immunologic-based therapies for acute kidney injury and chronic kidney disease (CKD). Furthermore, significant investment by startups in research & development activities in order to launch novel treatment for acute kidney injury is transforming the business landscape.

Acute Kidney Injury Treatment Market

Acute Kidney Injury Treatment Market Introduction

Acute kidney injury (AKI) is a sudden episode of kidney failure/damage that can range from minor loss of kidney functions to complete kidney failure. Diarrhea, feeling sick or being sick, dehydration, drowsiness, and confusion are some of the common symptoms of acute kidney injuries.

Treatment for kidney injuries primarily depends on the cause and extent of the injury. Experimental treatments for the management of AKIs primarily comprise vasoactive peptides, growth-factors, endothelin inhibitors, adhesion molecules, and bio-artificial kidneys. Aminophylline has also been used experimentally for prophylaxis, specifically against renal failure (RF).

Request a sample to get extensive insights into the Acute Kidney Injury Treatment Market

Increase in Geriatric Population and Rise in Incidence of Acute Kidney Injury

The geriatric population has increased in the past few years, especially in developed countries such as the U.S., Japan, and most countries in Western Europe. These countries have high geriatric population vis-à-vis their developing counterparts. This can be ascribed to the improvement in health care infrastructure, favorable reimbursement policies, and advancements in health care facilities. Access to multiple diagnostic and treatment services has improved, specifically in developed countries. This has increased the life expectancy of the population.

Studies indicate that a majority (60% to 70%) of the elderly population is susceptible to acute kidney injury. Increase in geriatric population leads to high rate of ailments. This, in turn, is likely to augment the demand for acute kidney injury medications across the globe in the near future.

Around 13.3 million people across the world are estimated to be affected by acute kidney injury. The patient population is expected to rise substantially in the next few decades. Increase in incidence rate of acute kidney injury is creating a significant socioeconomic impact across the globe.

Surge in Number of Critical Care Admissions

According to an independent research, multiple system organ failure (MSOF) and other comorbidities contribute to high mortality rate among intensive care unit (ICU) patients. However, the mortality rate of AKI stands at 50% to 80% in ICU patients. Acute kidney injury (AKI) often occurs in intensive care units (ICUs), thus leading to high expenditure along with adverse clinical outcomes.

AKI is primarily associated with incomplete kidney recovery and increase in mortality and cost. This is likely to lead to a surge in demand for effective acute kidney failure treatment, which is projected to accelerate acute kidney injury treatment market progress.

Request a custom report on Acute Kidney Injury Treatment Market

Lifesaving Treatment Propelling Dialysis Segment

In terms of treatment, the dialysis segment accounted for major market share in 2021. Dialysis facilitates the survival of critically ill patients with AKIs. The total number of dialysis service centers has increased across the globe. This is anticipated to drive the dialysis segment during the forecast period.

According to the United States Renal Data system (USRDS), the U.S. had more than 7,500 dialysis centers in 2021. Governments of developing countries are setting up new dialysis centers and improving the existing ones. In November 2022, Southlake Biotech, an innovative biotech-firm, announced that it will receive US$ 33.0 Mn in financing to advance its portfolio of kidney disease treatments.

Growth in Incidence Bolstering Pre-renal Acute Kidney Injury Segment

Pre-renal acute kidney injuries account for 55% to 65% of cases with acute kidney injury (AKIs). Introduction of novel drugs and increase in investment in research and innovation are likely to augment the pre-renal acute kidney injury segment during the forecast period.

Regional Outlook of Acute Kidney Injury Treatment Market

North America accounted for around 43.0% share of the global industry in 2021. Increase in geriatric population, rise in acute kidney injury patient pool, promising clinical pipeline, and development of advanced & efficient products are fueling the North America market expansion. Rise in number of key players; increase in acquisitions, mergers, and collaborations; government approval for new products; and surge in adoption of advanced products are boosting business outlook in the region.

Asia Pacific is projected to be a rapidly growing region for AKI treatment during the forecast period. Increase in geriatric population; rise in prevalence of chronic diseases, which are high risk factors for acute kidney injury; growth in urbanization; and surge in critical care admissions are boosting the region's market statistics. Government initiatives in the healthcare sector, increase in investment in R&D activities, and rise in presence of global players are fueling the demand for AKI treatment in Asia Pacific.

Analysis of Key Players

The acute kidney injury treatment market is highly consolidated, with the presence of small number of dominant players. Companies are engaging in strategic alliances to increase revenue and market share. Players are also adopting strategies such as product line expansion and acquisitions & mergers to broaden their business footprint.

Major players in the acute kidney injury treatment sector are Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem.

Key Developments in Acute Kidney Injury Treatment Market

  • In March 2021, B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services, and CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation, announced the launch of a global co-marketing agreement to promote the use of CytoSorb
  • In March 2021, Critical Path Institute (C-Path), a nonprofit, independent organization, announced the official launch of Acute Kidney Injury (AKI) Project in collaboration with the U.S. Food and Drug Administration. The company proposed a plan to develop a suite of prognostic tools in order to enhance the prediction and detection of drug-induced kidney injury (DIKI).
  • In November 2020, Vifor Pharma, a Switzerland-based drug manufacturer, agreed to pay U.S.-based Angion Biomedica up to US$ 80.0 Mn for rights to experimental kidney drug ANG-3777

The acute kidney injury treatment industry report profiles leading players based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Global Acute Kidney Injury Treatment Market Snapshot

Attribute

Detail

Size in 2021

US$ 1.5 Bn

Forecast Value in 2031

More than US$ 3.0 Bn

Growth Rate

(CAGR) for 2022-2031

7.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis.

Competition Landscape

  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Treatment
    • Dialysis
    • Supportive Care
  • Type
    • Pre-renal Acute Kidney Injury
    • Intrinsic Renal Acute Kidney Injury
    • Post-renal Acute Kidney Injury
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Angion Biomedica Corp.
  • AM-Pharma
  • Quark Pharmaceuticals, Inc.
  • Baxter International, Inc.
  • Fresenius Medical Care AG & Co. KGaA.
  • B. Braun Melsungen AG
  • Asahi Kasei Medical Co., Ltd.
  • LG Chem

Customization Scope

Available upon request

Pricing

Available upon request

Acute Kidney Injury Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global acute kidney injury treatment market in 2021?

The industry was valued at US$ 1.5 Bn in 2021.

How big will be the business in 2031?

It is projected to reach more than US$ 3.0 Bn by 2031.

What will be the CAGR during the forecast period?

The global market is anticipated to grow at a CAGR of 7.5% from 2022 to 2031.

Which are the prominent trends that affect acute kidney injury treatment industry growth?

Increase in incidence of acute kidney injury, surge in number of dialysis centers, large geriatric population, and effective governmental initiatives taken to improve healthcare sector.

Which region will account for major share of the sector?

North America is expected to account for major share during the forecast period.

Who are the prominent players in the acute kidney injury treatment industry?

Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Acute Kidney Injury Treatment Market: Market Snapshot

4. Market Overview

    4.1. Global Acute Kidney Injury Treatment Market: Overview

    4.2. Global Acute Kidney Injury Treatment Market: Key Industry Developments

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Acute Kidney Injury Treatment Market Revenue Projection, 2017–2031

    4.5. Global Acute Kidney Injury Treatment Market Outlook

5. Market Outlook

    5.1. Acute Kidney Injury Epidemiology: Overview

    5.2. Key Merger and Acquisitions

    5.3. Pipeline Analysis

    5.4. CCOVID-19 Impact on Industry

6. Global Acute Kidney Injury Treatment Market Analysis, by Treatment

    6.1. Key Findings

    6.2. Introduction

    6.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Treatment

    6.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Treatment

        6.4.1. Dialysis

        6.4.2. Supportive Care

    6.5. Global Acute Kidney Injury Treatment Market Analysis, by Treatment

7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, by Type

    7.1. Key Findings

    7.2. Introduction

    7.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Type

    7.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Type

        7.4.1. Pre-renal Acute Kidney Injury

        7.4.2. Intrinsic Renal Acute Kidney Injury

        7.4.3. Post-renal Acute Kidney Injury

    7.5. Global Acute Kidney Injury Treatment Market Analysis, by Type

8. Global Acute Kidney Injury Treatment Market Analysis, by End-user

    8.1. Key Findings

    8.2. Introduction

    8.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by End-user

    8.4. Global Acute Kidney Injury Treatment Market Value Forecast, by End-user

        8.4.1. Hospitals

        8.4.2. Ambulatory Surgical Centers

        8.4.3. Others

    8.5. Global Acute Kidney Injury Treatment Market Analysis, by End-user

9. Global Acute Kidney Injury Treatment Market Analysis, by Region

    9.1. Global Acute Kidney Injury Treatment Market Scenario, by Country

    9.2. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Region

    9.3. Global Acute Kidney Injury Treatment Market Value Forecast, by Region

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

10. North America Acute Kidney Injury Treatment Market Analysis

    10.1. Key Findings

    10.2. North America Acute Kidney Injury Treatment Market Overview

    10.3. North America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country

    10.4. North America Acute Kidney Injury Treatment Market Forecast, by Country

        10.4.1. U.S.

        10.4.2. Canada

    10.5. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment

    10.6. North America Acute Kidney Injury Treatment Market Forecast, by Treatment

        10.6.1. Dialysis

        10.6.2. Supportive Care

    10.7. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type

    10.8. North America Acute Kidney Injury Treatment Market Forecast, by Type

        10.8.1. Pre-renal Acute Kidney Injury

        10.8.2. Intrinsic Renal Acute Kidney Injury

        10.8.3. Post-renal Acute Kidney Injury

    10.9. North America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user

    10.10. North America Acute Kidney Injury Treatment Market Forecast, by End-user

        10.10.1. Hospitals

        10.10.2. Ambulatory surgical centers

        10.10.3. Others

    10.11. North America Acute Kidney Injury Treatment Market Attractiveness Analysis

11. Europe Acute Kidney Injury Treatment Market Analysis

    11.1. Key Findings

    11.2. Europe Acute Kidney Injury Treatment Market Overview

    11.3. Europe Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.4. Europe Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region

        11.4.1. Germany

        11.4.2. U.K.

        11.4.3. France

        11.4.4. Italy

        11.4.5. Spain

        11.4.6. Rest of Europe

    11.5. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment

    11.6. Europe Acute Kidney Injury Treatment Market Forecast, by Treatment

        11.6.1. Dialysis

        11.6.2. Supportive Care

    11.7. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type

    11.8. Europe Acute Kidney Injury Treatment Market Forecast, by Type

        11.8.1. Pre-renal Acute Kidney Injury

        11.8.2. Intrinsic Renal Acute Kidney Injury

        11.8.3. Post-renal Acute Kidney Injury

    11.9. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by End-user

    11.10. Europe Acute Kidney Injury Treatment Market Forecast, by End-user

        11.10.1. Hospitals

        11.10.2. Ambulatory Surgical Centers

        11.10.3. Others

    11.11. Europe Acute Kidney Injury Treatment Market Attractiveness Analysis

12. Asia Pacific Acute Kidney Injury Treatment Market Analysis

    12.1. Key Findings

    12.2. Asia Pacific Acute Kidney Injury Treatment Market Overview

    12.3. Asia Pacific Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.4. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region

        12.4.1. China

        12.4.2. India

        12.4.3. Japan

        12.4.4. Australia & New Zealand

        12.4.5. Rest of Asia Pacific

    12.5. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment

    12.6. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Treatment

        12.6.1. Dialysis

        12.6.2. Supportive Care

    12.7. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type

    12.8. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Type

        12.8.1. Pre-renal Acute Kidney Injury

        12.8.2. Intrinsic Renal Acute Kidney Injury

        12.8.3. Post-renal Acute Kidney Injury

    12.9. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by End-user

    12.10. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by End-user

        12.10.1. Hospitals

        12.10.2. Ambulatory Surgical Centers

        12.10.3. Others

    12.11. Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis

13. Latin America Acute Kidney Injury Treatment Market Analysis

    13.1. Key Findings

    13.2. Latin America Acute Kidney Injury Treatment Market Overview

    13.3. Latin America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.4. Latin America Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region

        13.4.1. Brazil

        13.4.2. Mexico

        13.4.3. Rest of Latin America

    13.5. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment

    13.6. Latin America Acute Kidney Injury Treatment Market Forecast, by Treatment

        13.6.1. Dialysis

        13.6.2. Supportive Care

    13.7. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type

    13.8. Latin America Acute Kidney Injury Treatment Market Forecast, by Type

        13.8.1. Pre-renal Acute Kidney Injury

        13.8.2. Intrinsic Renal Acute Kidney Injury

        13.8.3. Post-renal Acute Kidney Injury

    13.9. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user

    13.10. Latin America Acute Kidney Injury Treatment Market Forecast, by End-user

        13.10.1. Hospitals

        13.10.2. Ambulatory Surgical Centers

        13.10.3. Others

    13.11. Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis

14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis

    14.1. Key Findings

    14.2. Middle East & Africa Acute Kidney Injury Treatment Market Overview

    14.3. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region

    14.4. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region

        14.4.1. GCC Countries

        14.4.2. South Africa

        14.4.3. Rest of Middle East and Africa

    14.5. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment

    14.6. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Treatment

        14.6.1. Dialysis

        14.6.2. Supportive Care

    14.7. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type

    14.8. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Type

        14.8.1. Pre-renal Acute Kidney Injury

        14.8.2. Intrinsic Renal Acute Kidney Injury

        14.8.3. Post-renal Acute Kidney Injury

    14.9. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by End-user

    14.10. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by End-user

        14.10.1. Hospitals

        14.10.2. Ambulatory Surgical Centers

        14.10.3. Others

    14.11. Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis

15. Competition Landscape

    15.1. Acute Kidney Injury Treatment Market Share Analysis, by Company, 2021

    15.2. Competition Matrix

    15.3. Company Profiles

        15.3.1. Angion Biomedica Corp

            15.3.1.1. Company Details

            15.3.1.2. Business Overview

            15.3.1.3. Financial Overview

            15.3.1.4. Strategic Overview

            15.3.1.5. SWOT Analysis

        15.3.2. AM-Pharma

            15.3.2.1. Company Details

            15.3.2.2. Business Overview

            15.3.2.3. Financial Overview

            15.3.2.4. Strategic Overview

            15.3.2.5. SWOT Analysis

        15.3.3. Quark Pharmaceuticals, Inc.

            15.3.3.1. Company Details

            15.3.3.2. Business Overview

            15.3.3.3. Financial Overview

            15.3.3.4. Strategic Overview

            15.3.3.5. SWOT Analysis

        15.3.4. Baxter International, Inc.

            15.3.4.1. Company Details

            15.3.4.2. Business Overview

            15.3.4.3. Financial Overview

            15.3.4.4. Strategic Overview

            15.3.4.5. SWOT Analysis

        15.3.5. Fresenius Medical Care AG & Co. KGaA

            15.3.5.1. Company Details

            15.3.5.2. Business Overview

            15.3.5.3. Financial Overview

            15.3.5.4. Strategic Overview

            15.3.5.5. SWOT Analysis

        15.3.6. LG Chem

            15.3.6.1. Company Details

            15.3.6.2. Business Overview

            15.3.6.3. Financial Overview

            15.3.6.4. Strategic Overview

            15.3.6.5. SWOT Analysis

        15.3.7. Asahi Kasei Medical Co., Ltd.

            15.3.7.1. Company Details

            15.3.7.2. Business Overview

            15.3.7.3. Financial Overview

            15.3.7.4. Strategic Overview

            15.3.7.5. SWOT Analysis

        15.3.8. B. Braun Melsungen AG

            15.3.8.1. Company Details

            15.3.8.2. Business Overview

            15.3.8.3. Financial Overview

            15.3.8.4. Strategic Overview

            15.3.8.5. SWOT Analysis

List of Tables

Table 01: Acute Kidney Injury Treatment Market Merger and Acquisition Deals

Table 02: Acute Kidney Injury Treatment Market Merger and Acquisition Deals

Table 03: AKI Pipeline Analysis

Table 04: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031

Table 05: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 06: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Global Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 08: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 09: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 10: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031

Table 11: North America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 14: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031

Table 15: Europe Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 18: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031

Table 19: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 22: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031

Table 23: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 25: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Type, 2017–2031

Table 26: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by Treatment, 2017–2031

Table 27: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Distribution, by Region, 2021 and 2031

Figure 02: Global Acute Kidney Injury Treatment Market Revenue Projection (US$ Mn), 2017–2031

Figure 03: Global Acute Kidney Injury Treatment Market Value Share, by Treatment, 2021

Figure 04: Global Acute Kidney Injury Treatment Market Value Share, by Region, 2021

Figure 05: Global Acute Kidney Injury Treatment Market Value Share, by Type, 2021

Figure 06: Global Acute Kidney Injury Treatment Market Value Share, by End-user, 2021

Figure 07: Global Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 08: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 09: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Dialysis, 2017–2031

Figure 10: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Supportive Care, 2017–2031

Figure 11: Global Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031

Figure 12: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031

Figure 13: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Pre-renal Acute Kidney Injury, 2017–2031

Figure 14: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Intrinsic Renal Acute Kidney Injury, 2017–2031

Figure 15: Global Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Post-renal Acute Kidney Injury, 2017–2031

Figure 16: Global Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031

Figure 17: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 18: Global Acute Kidney Injury Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2031

Figure 19: Global Acute Kidney Injury Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2017–2031

Figure 20: Global Acute Kidney Injury Treatment Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2031

Figure 21: Global Acute Kidney Injury Treatment Market Value Share, by Region, 2021 and 2031 

Figure 22: Global Acute Kidney Injury Treatment Market Attractiveness Analysis, by Region, 2022–2031

Figure 23: North America Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031

Figure 24: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Country, 2021 and 2031

Figure 25: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country, 2022–2031

Figure 26: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031

Figure 27: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031

Figure 28: North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 29: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 30: North America Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031

Figure 31: North America Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 32: Europe Acute Kidney Injury Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031

Figure 33: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 34: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 35: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031

Figure 36: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031

Figure 37: Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 38: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 39: Europe Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031

Figure 40: Europe Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 41: Asia Pacific Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031

Figure 42: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 43: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 44: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031

Figure 45: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031

Figure 46: Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 47: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 48: Asia Pacific Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031

Figure 49: Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 50: Latin America Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031

Figure 51: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 52: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 53: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031

Figure 54: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031

Figure 55: Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 56: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 57: Latin America Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031

Figure 58: Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 59: Middle East & Africa Acute Kidney Injury Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031

Figure 60: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 61: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 62: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type, 2021 and 2031

Figure 63: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by Type, 2022–2031

Figure 64: Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment, 2021 and 2031

Figure 65: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by Treatment, 2022–2031

Figure 66: Middle East & Africa Acute Kidney Injury Treatment Market Value Share, by End-user, 2021 and 2031

Figure 67: Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 68: Baxter International, Inc. Breakdown of Net Sales, by Region, 2018

Figure 69: Baxter International, Inc. R&D Intensity and Sales & Marketing Intensity - Company Level (US$ Mn), 2019–2021

Figure 70: Baxter International, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2019–2021

Figure 71: Baxter International, Inc. Breakdown of Net Sales, by Business Segment, 2021

Figure 72: Fresenius Medical Care AG & Co. KGaA Breakdown of Net Sales, by Region, 2021

Figure 73: Fresenius Medical Care AG & Co. KGaA R&D Intensity and Sales & Marketing Intensity - Company Level (US$ Mn), 2019–2021

Figure 74: Fresenius Medical Care AG & Co. KGaA Revenue (US$ Mn) and Y-o-Y Growth (%), 2019–2021

Figure 75: Fresenius Medical Care AG & Co. KGaA Breakdown of Net Sales, by Business Segment (Health Care Services), 2018

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

702

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved